Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

HeartMate 3 heart pump gets FDA approval as destination therapy

The HeartMate 3 left ventricular assist device (LVAD) has gained FDA approval for advanced heart failure patients ineligible for a transplant, manufacturer Abbott announced Oct. 19.

Nonfemoral TAVR tied to greater mortality in frail seniors

Nonfemoral access routes for transcatheter aortic valve replacement (TAVR) are associated with significantly higher 30-day mortality rates for frail patients but not among other older adults, according to a post hoc analysis of the FRAILTY-AVR study published in JACC: Cardiovascular Interventions.

Thumbnail

Bariatric surgery linked to 40% reduction in CV events for type 2 diabetics

Bariatric surgery may help reduce cardiovascular events beyond normal treatment with medication and lifestyle modifications for patients with severe obesity and type 2 diabetes, suggests an observational study published in JAMA.

Thumbnail

Boston Children’s criteria IDs kids at risk for arrhythmias during stress tests

Clinically significant arrhythmias are rare during exercise stress tests (ESTs) in pediatric heart patients, researchers reported in JACC: Clinical Electrophysiology, but those most at risk for life-threatening events can be identified from a set of predefined risk factors like cardiomyopathy and ventricular dysfunction.

Thumbnail

Image-guided atherectomy system for smaller vessels gains CE mark

Avinger announced on Oct. 18 its Pantheris SV atherectomy device has gained CE mark approval, allowing it to be sold commercially in Europe. The system extends the plaque-removing technique for peripheral artery disease to smaller vessels with diameters between 2 and 4 millimeters.

Thumbnail

Bedside troponin test can rule out AMI within 15 minutes

A point-of-care troponin assay that yields results within about 15 minutes was equally effective at ruling out acute myocardial infarction (AMI) as a high-sensitivity troponin I test performed in a laboratory setting, researchers reported in JAMA Cardiology.

Thumbnail

AHA, AMA recognize 802 practices for efforts to control hypertension

A year after its launch, the American Heart Association and American Medical Association’s joint Target: BP Recognition Program, an effort to reduce the rate of uncontrolled hypertension in the U.S., has reached 802 members, the organizations announced this week.

Prior PCI does little to affect CABG outcomes

Despite past research suggesting a history of percutaneous coronary intervention (PCI) could complicate coronary artery bypass grafting (CABG) outcomes, a study published in the Journal of the American Heart Association Oct. 16 reported prior PCI has little to do with how a patient recovers from subsequent surgeries.